Annual Total Long Term Liabilities
$5.80 M
-$604.00 K-9.44%
December 31, 2023
Summary
- As of February 8, 2025, AGRX annual total long term liabilities is $5.80 million, with the most recent change of -$604.00 thousand (-9.44%) on December 31, 2023.
- During the last 3 years, AGRX annual total long term liabilities has fallen by -$10.59 million (-64.62%).
Performance
AGRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$10.65 M
+$9.15 M+613.13%
June 1, 2024
Summary
- As of February 8, 2025, AGRX quarterly total long term liabilities is $10.65 million, with the most recent change of +$9.15 million (+613.13%) on June 1, 2024.
- Over the past year, AGRX quarterly long term liabilities has stayed the same.
Performance
AGRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AGRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.4% | 0.0% |
| 3 y3 years | -64.6% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
AGRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.4% | at low | at high | -94.8% |
| 5 y | 5-year | -64.6% | -100.0% | -35.2% | -100.0% |
| alltime | all time | -93.1% | -100.0% | -86.5% | -100.0% |
Agile Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $10.65 M(+613.1%) |
| Mar 2024 | - | $1.49 M(-74.2%) |
| Dec 2023 | $5.80 M(-9.4%) | $5.80 M(+0.6%) |
| Sep 2023 | - | $5.76 M(-38.6%) |
| Jun 2023 | - | $9.38 M(+102.9%) |
| Mar 2023 | - | $4.63 M(-27.7%) |
| Dec 2022 | $6.40 M(+4.2%) | $6.40 M(+1063.6%) |
| Sep 2022 | - | $550.00 K(-12.7%) |
| Jun 2022 | - | $630.00 K(-11.0%) |
| Mar 2022 | - | $708.00 K(-88.5%) |
| Dec 2021 | $6.14 M(-62.5%) | $6.14 M(-62.6%) |
| Sep 2021 | - | $16.43 M(+2.5%) |
| Jun 2021 | - | $16.04 M(+2.6%) |
| Mar 2021 | - | $15.64 M(-4.5%) |
| Dec 2020 | $16.38 M(>+9900.0%) | $16.38 M(+1.9%) |
| Sep 2020 | - | $16.08 M(+1.9%) |
| Jun 2020 | - | $15.78 M(+2.0%) |
| Mar 2020 | - | $15.47 M(>+9900.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2019 | - | $34.00 K(-58.5%) |
| Jun 2019 | - | $82.00 K(-35.9%) |
| Mar 2019 | - | $128.00 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2017 | - | $5.89 M(-25.3%) |
| Jun 2017 | - | $7.89 M(-16.2%) |
| Mar 2017 | - | $9.42 M(-11.2%) |
| Dec 2016 | $10.61 M(-17.7%) | $10.61 M(-12.2%) |
| Sep 2016 | - | $12.08 M(+20.7%) |
| Jun 2016 | - | $10.01 M(-12.8%) |
| Mar 2016 | - | $11.47 M(-11.0%) |
| Dec 2015 | $12.90 M(+31.2%) | $12.90 M(-16.2%) |
| Sep 2015 | - | $15.39 M(+0.9%) |
| Jun 2015 | - | $15.26 M(+0.9%) |
| Mar 2015 | - | $15.13 M(+53.9%) |
| Dec 2014 | $9.83 M(-87.6%) | $9.83 M(-12.6%) |
| Sep 2014 | - | $11.24 M(-10.9%) |
| Jun 2014 | - | $12.62 M(-83.9%) |
| Mar 2014 | - | $78.39 M(-0.8%) |
| Dec 2013 | $79.00 M(-6.0%) | $79.00 M |
| Dec 2012 | $84.02 M | - |
FAQ
- What is Agile Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Agile Therapeutics?
- What is Agile Therapeutics annual total long term liabilities year-on-year change?
- What is Agile Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Agile Therapeutics?
- What is Agile Therapeutics quarterly long term liabilities year-on-year change?
What is Agile Therapeutics annual total long term liabilities?
The current annual total long term liabilities of AGRX is $5.80 M
What is the all time high annual total long term liabilities for Agile Therapeutics?
Agile Therapeutics all-time high annual total long term liabilities is $84.02 M
What is Agile Therapeutics annual total long term liabilities year-on-year change?
Over the past year, AGRX annual total long term liabilities has changed by -$604.00 K (-9.44%)
What is Agile Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of AGRX is $10.65 M
What is the all time high quarterly long term liabilities for Agile Therapeutics?
Agile Therapeutics all-time high quarterly total long term liabilities is $79.00 M
What is Agile Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, AGRX quarterly total long term liabilities has changed by $0.00 (0.00%)